Quantitative analysis
Linearity (Supplementary Table S9 ) was evaluated by analyzing the standard solutions of Ber, Bai and Jas at seven different concentration levels. Based on the obtained results, the linearities of the analytical response across the studied range were excellent, with correlation coefficients (r 2 ) at 0.9994, 0.9992 and 0.9991, respecively. Sensitivity of the method was evaluated by determining limits of detection (LOD) and the pre-determined values of quantitation limits (LOQ). LOD and LOQ were defined at the concentration with a signal-to-noise ratio (determined by peak height) of at least 3 and 10, respectively. The parameter was determined empirically by triplicate analysis of a series of concentrations of standard solution.
Method precision was checked by intra-day and inter-day variability. The intra-day variability study was conducted by the injection of the same standard solution at six consecutive times in the same day. The inter-day variability study was conducted for three successive days using the same solution. The precision were expressed in terms of relative standard deviation (RSD). The RSD values obtained from run-to-run and day-to-day precision studies were summarized in Supplementary   Table S10 . Based on our results, the developed method was precise.
The recovery rate was performed by adding a known amount of standards into a certain amount of HLJDD extract. The mixture was extracted and analysed using the method mentioned above. Three replicates were performed for the test. The recovery of Ber, Bai and Jas was summarized in Supplementary Table S10 .
Sample collection
The rats were deeply anesthetized with 3.5% chloral hydrate (350 mg/kg body weight) 24 hours after reperfusion and then sacrificed. Blood was collected from the abdominal aorta, and the serum samples were obtained by centrifugation at 2,000×g
for 10 min and were stored at −80 °C before the experiments. Brain tissues were quickly removed, weighed, and rinsed with cold phosphate-buffered saline (PBS). An aliquot of brain samples was frozen stored at −80 °C for 1 H NMR studies, and another brain portion used for histological examination was fixed in neutral buttered formalin (10% formalin in 0.08 M sodium phosphate, pH 7.4).
H NMR spectroscopic measurement of serum and brain tissues
After thawing, serum samples (300 μl) were added to 300 μl D The supernatants (550 μL) were then pipetted into 5-mm NMR tubes for NMR recording. Frozen brain tissues (200-300 mg) were homogenized in a mixture of volumetric equivalent acetonitrile and water (5 mL/g tissue) in an ice/water bath and centrifuged at 12,000×g for 10 min at 4 °C . 
Spectral pre-processing
The spectra for all samples were manually phased and baseline corrected and referenced to TSP at 0.0 ppm, using Bruker Topspin 3.0 software (Bruker GmbH, Karlsruhe, Germany). The 1 H NMR spectra were automatically exported to ASCII files using MestReNova (Version 8.0.1, Mestrelab Research SL), which were then imported into "R" (http://cran.r-project.org/) and aligned with an in-house developed R-script to further reduce phase and baseline distortions. The one-dimensional (1D) spectra were converted to an appropriate format for statistical analysis by automatically segmenting each spectrum into 0.015-ppm integrated spectral regions (buckets) between 0.2 and 10 ppm. The region of the residual water and affected signals (4.70-9 .70 for serum and 4.65-5.25 for brain extracts) was removed. To account for different dilutions of samples, all binned spectra were probability quotient normalized and then mean-centred before further multivariate analysis.
Data analysis
The mean-centred and Pareto-scaled NMR data were analysed by principal component analysis (PCA) and OPLS-DA. PCA is an exploratory unsupervised method to maximize the separation by providing model-free approaches for determining the latent or intrinsic information in the dataset. However, no clustering was observed when variables were not selected. OPLS-DA determined PLS components that are orthogonal to the grouping and was used to concentrate group discrimination into the first component with remaining unrelated variations contained in subsequent components. All OPLS-DA models were validated by a repeated two-fold cross-validation method and permutation test (2000 times) [1] . The parameters R 2 and Q 2 reflected the goodness of fitness and the predictive ability of the models, respectively. The p-value of the permutation test denoted the number of times that the permutated data yielded a better result than the one using the original labels.
The fold change values of metabolites among different groups were calculated. The
Benjamini & Hochberg method [2] was used to adjust the p-values for controlling the false discovery rate in multiple comparisons using scripts written in R language.
Real-time quantitative RT-PCR analysis
Total RNA was extracted from ischemic hippocampus tissue using RNAiso Plus Supplementary Table S1 .
Western blot analysis
Western blot analysis was performed at 24 h after reperfusion. Cell proteins in ischemic penumbra were extracted from the fresh cerebral cortex. Briefly, the samples were homogenized in 1xRIPA lysis buffer (50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 0.25% deoxycholic acid, 1% NP-40, 1 mM EDTA, and phosphatase and protease inhibitors) (Amresco, Solon, USA) to extract the total proteins. Cytosolic and nuclear extractions were performed using a cytosolic/nuclei isolation kit (Beyotime Biotechnology Co., Ltd., Nanjing, China), according to the manufacturer's protocols.
Protein concentrations were measured using the bicinchoninic acid protein ( Chemiluminescence substrate (ECL Plus) was used to incubate the blots and band intensities were analysed using the ChemiDOC™ XRS+ system (Bio-Rad Laboratories, Hercules, CA, USA). PCNA and -actin proteins were considered as loading controls.
Pharmacokinetic study
Blood samples, ca. 300 µL, were collected at 15 min after drug administration and at 1 day, 3 day and 7 day after reperfusion. Plasma was harvested by centrifuging the blood sample at 4 º C and 2,000 × g for 10 min, and then stored at −80 º C until analysis. After anesthetization, the animals were then sacrificed at 1day, 3day and 7day after reperfusion. Brains were obtained at the time of death and quickly rinsed with normal saline, and then stored at −80 º C for analysis. Brains were accurately weighed (200 mg) and homogenized in 600 µL of deionized water under ice bath using a Potter-Elvehjem homogenizer.
Plasma sample/brain homogenate (100 µL) was spiked with 20 µL of 1-hydroxytacrine (IS) working solution (5 ng/mL) and mixed for 10 s, to which, 400 µL of methanol was added, and the mixture was vortexed for 3 min. The well-vortexed solution was then centrifuged at 14,000 × g for 5 min and 400 µL of the supernatant was transferred into a new centrifuge tube and dried. The residue was reconstituted in 100 µL methanol, centrifuged at 14,000 × g for 5 min, and 5 µL of the supernatant was injected into the HPLC-QTOF-MS/MS system for analysis.
Chromatographic separation was performed on an Agilent ZORBAX SB-C18
column ( Calibration standards for berberine, baicalin, jasminoidin were prepared by spiking 100 µL of blank plasma or brain homogenate with 10 µL of corresponding working solutions to yield final concentrations of 5, 10, 20, 50, 100, 200, 500, 1000 and 2000 ng/mL in rat plasma and 2, 5, 10, 20, 50, 100, 200, 500, 1000 and 2000 ng/mL in brain homogenate. QC samples were prepared in the same manner at concentrations of 4, 800 and 1600 ng/mL. The intra-day accuracy and precision were determined within 1 day by analysis of six replicates of QC samples at 4, 800 and 1600 ng/mL. The inter-day precision and accuracy were determined in 3 consecutive days. The accuracy and precision were expressed in terms of RE and RSD, respectively. The precision should not exceed 15% and accuracy should be within ± 15% for the QC samples. The intra-day and inter-day and precision of the assay method for all analytes in rat plasma and brain tissue were shown in Supplementary Table S12 .
The recovery was assessed by comparing the mean peak area of QC samples extracted from biological matrix with the peak area of reference standards prepared in reconstitute solvent. The matrix effect was evaluated by comparing the peak areas of analytes in the above mentioned standard solutions to those of the neat standards at the same concentration. The stability of berberine, baicalin and jasminoidin in rat plasma and brain extracts was investigated by analysis of three levels of QC samples stored at −80 ºC for two weeks (long-term stability), at 25 º C for 4 h (short-term stability) and after three freeze-thaw cycles (−80 ºC to 25 ºC). The data for the absolute recovery and matrix effect were summarized in Supplementary Table S13.
All matrix effects were considered acceptable in this method. The data for short-term stability, long-term stability, freeze-thaw stability and post-preparative stability were shown in Supplementary Tables S14 and 15 , also acceptable for routine analysis.
Brain/plasma disposition of berberine, baicalin and jasminoidin
The developed and validated method was applied to determine berberine, baicalin and jasminoidin in rat plasma and brain tissues after administration. The mean concentration-time curves of berberine, baicalin and jasminoidin in plasma and brain were shown in Supplementary Figure S7 .
Supplementary Table   Supplementary Table S1 Primers used Multiplicity: singlet (s), doublet (d), triplet (t), doublet of doublets (dd), quartets (q), multiplet (m). 
Supplementary

